Skip to content

Ticagrelor Related Compound 36 (DP8)

Ticagrelor Related Compound 36 (DP8)

Product Description
CAT No.
ALN-T023043
CAS No.
NA
Mol. F.
C23H28F2N6O4S
Mol. Wt.
522.6
Stock
Please Inquire
Chemical Name : (1S,2S,3S,5R)-5-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2-((1R,2S)-2-(3,4-difluorophenyl)cyclopropoxy)-3-(2-hydroxyethoxy)cyclopentan-1-ol
Smiles : FC1=C(F)C=CC([C@H]2[C@H](O[C@H]3[C@@H](O)[C@H](N4N=NC5=C4N=C(SCCC)N=C5N)C[C@@H]3OCCO)C2)=C1
Inchi : InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26)18-22(28-23)31(30-29-18)15-10-17(20(33)19(15)32)35-6-5-34-16-9-12(16)11-3-4-13(24)14(25)8-11/h3-4,8,12,15-17,19-20,32-33H,2,5-7,9-10H2,1H3,(H2,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1

Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method

By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.nFrom World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.

Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies

By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav – From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724

Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)

By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42

Request For Quotation